Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years-Reference-Cited by-同舟云学术

Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years

Published:2012-01-30 Issue:7 Volume:54 Page:922-928
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clinical Infectious Diseases

Author:

Schmader K. E.,Levin M. J.,Gnann J. W.,McNeil S. A.,Vesikari T.,Betts R. F.,Keay S.,Stek J. E.,Bundick N. D.,Su S.-C.,Zhao Y.,Li X.,Chan I. S. F.,Annunziato P. W.,Parrino J.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/54/7/922/847376/cir970.pdf

Reference27 articles.

1. Herpes Zoster

2. Acute Pain in Herpes Zoster and Its Impact on Health-Related Quality of Life

3. The Impact of Acute Herpes Zoster Pain and Discomfort on Functional Status and Quality of Life in Older Adults

4. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life

5. Analgesic Therapy in Postherpetic Neuralgia: A Quantitative Systematic Review

Cited by 373 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipo-pam™ adjuvanted herpes zoster vaccine induces potent gE-specific cellular and humoral immune responses;npj Vaccines;2024-08-17

2. Cost-Effectiveness Analysis of Herpes Zoster Vaccination in a Chinese Population: Recombinant Subunit Vaccine versus Live Attenuated Vaccine;Vaccines;2024-08-01

3. IDENTIFYING PLAUSIBLE RANGES FOR DIFFERENTIAL VACCINE EFFICACY ACROSS HIGH- AND LOW-INCOME SETTINGS: A SYSTEMATIC REVIEW, DESCRIPTIVE META-ANALYSIS, AND ILLUSTRATIVE EVIDENCE ANALYSIS;2024-08-01

4. National trends and disparities in herpes zoster vaccination among US older adults with chronic obstructive pulmonary disease, 2008 to 2022;American Journal of Infection Control;2024-08

5. What is Different about Recombinant Herpes Zoster Vaccine?;The Korean Journal of Medicine;2024-08-01